北京昭衍生物技术有限公司秉承“服务药物创新、造福人类社会”的宗旨,致力于成为的生物制药产业服务平台。我们将与客户共同面对棘手的疾病，坚持生物制药技术的创新，整合资源加速生物药物研发进程，为生物制药产业创造更高价值，为患者提供更多安全有效的健康方案。 我们将整合全球资源为客户提供一站式的生物药研发及生产服务： ² 在美国，我们的园区坐落于美国旧金山湾区，拥有美国GMP认证的生产车间，目前已建成千升级的生产规模； ² 在中国，我们拟建成符合中国、美国及欧盟GMP标准的十万升规模的产线，建造冻干、水针、预充针等多种剂型的制剂车间； ² 我们将建成、开放的、一站式生物药物分析平台； ² 我们将打造卓越的生物技术团队、制药系统工程运维团队，依托先进的技术资源，实现工艺、工程标准与技术水平的接轨。 ² 我们用丰富的经验和坚持不懈的努力持续地提供多产品类型、多元化的服务，服务范围将涵盖重组蛋白药物、抗体药物、基因以及诊断试剂等多产品类型，覆盖从生物药物的概念到商业化生产的全过程。
Beijing Zhao Derivative Technology Co., Ltd. is committed to becoming a biopharmaceutical industry service platform by adhering to the tenet of “Serving Drug Innovation and Benefiting Human Society”. We will face difficult diseases with our customers, adhere to the innovation of biopharmaceutical technology, integrate resources to accelerate the development of biopharmaceuticals, create higher value for the biopharmaceutical industry, and provide patients with more safe and effective health programs. We will integrate global resources to provide customers with one-stop biopharmaceutical R&D and production services: 2 In the United States, our park is located in the San Francisco Bay Area of the United States, and has a US GMP-certified production workshop. Currently, it has built a scale of production scale; 2 In China, we plan to build a production line of 100,000 liters that meets the GMP standards of China, the United States and the European Union, and build a workshop for various formulations such as freeze-dried, water-needle, and pre-filled needles; 2 We will build and open One-stop biopharmaceutical analysis platform; 2 We will build a superior biotechnology team, pharmaceutical system engineering operation and maintenance team, relying on advanced technical resources to achieve the integration of process, engineering standards and technical level. 2 We use our extensive experience and unremitting efforts to continuously provide multi-product types and diversified services. The scope of services will cover multi-product types such as recombinant protein drugs, antibody drugs, genes and diagnostic reagents, covering the concept of biopharmaceuticals. The whole process of commercial production.